# Clinical Trial to Assess the Safety and Pharmacokinetics of DA-2802 319mg and Viread 300mg in Healthy Male Volunteers

> **NCT02557594** · PHASE1 · COMPLETED · sponsor: **Dong-A ST Co., Ltd.** · enrollment: 36 (actual)

## Conditions studied

- Healthy

## Interventions

- **DRUG:** Viread 300mg
- **DRUG:** DA-2802 319mg

## Key facts

- **NCT ID:** NCT02557594
- **Lead sponsor:** Dong-A ST Co., Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2015-10-06
- **Primary completion:** 2015-11-17
- **Final completion:** 2016-03-08
- **Target enrollment:** 36 (ACTUAL)
- **Last updated:** 2017-04-12


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02557594

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02557594, "Clinical Trial to Assess the Safety and Pharmacokinetics of DA-2802 319mg and Viread 300mg in Healthy Male Volunteers". Retrieved via AI Analytics 2026-06-14 from https://api.ai-analytics.org/clinical/NCT02557594. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*